You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NSCLC

Showing 5126 - 5150 of 5,404
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Knoxville (erlotinib and bortezomib)

Terminated
  • NSCLC
  • erlotinib and bortezomib
  • Knoxville, Tennessee
    University of Tennesee
Feb 16, 2011

Lung Cancer Trial in Buffalo (drug, genetic, procedure)

Completed
  • Lung Cancer
  • gemcitabine hydrochloride
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 7, 2011

Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor

Completed
  • Non Small Cell Lung Cancer
    • Changhua, Taiwan
    • +5 more
    Sep 26, 2011

    Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Completely

    Unknown status
    • Non-small Cell Lung Cancer
      • Chengdu, Sichuan, China
        Cancer Hospital of Sichuan Province
      Dec 9, 2010

      NSCLC Trial in Seoul (Gemcitabine plus cisplatin, pemetrexed plus cisplatin)

      Unknown status
      • Non-small Cell Lung Cancer
      • Gemcitabine plus cisplatin
      • pemetrexed plus cisplatin
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jul 22, 2011

      Advanced Cancer, NSCLC Trial in United States (MKC-1, pemetrexed)

      Completed
      • Advanced Cancer
      • Non-Small Cell Lung Cancer
      • Indianapolis, Indiana
      • +3 more
      Jan 19, 2012

      NSCLC Trial in United States (Exisulind)

      Completed
      • Non-Small Cell Lung Cancer
      • Birmingham, Alabama
      • +113 more
      Oct 18, 2011

      Cancer, Non-small-cell Lung Cancer, Colorectal Cancer Trial in United States (XL281, famotidine)

      Completed
      • Cancer
      • +4 more
      • Scottsdale, Arizona
      • +5 more
      Oct 11, 2011

      Advanced Solid Tumors Trial in Tampa, Glasgow (OSI-930 and erlotinib)

      Completed
      • Advanced Solid Tumors
      • OSI-930 and erlotinib
      • Tampa, Florida
      • +1 more
      Sep 26, 2011

      s and Preferences of Patients Suffering From Advanced Non-small

      Terminated
      • Lung Cancer
      • Non-small Cell Lung Cancer
        • Berlin, Germany
        • +7 more
        Dec 9, 2010

        NSCLC Trial (Chemoradiotherapy Regimen between PC and PE)

        Completed
        • Non-Small Cell Lung Cancer
        • Chemoradiotherapy Regimen between PC and PE
        • (no location specified)
        Dec 16, 2011

        Advanced Solid Tumors Trial in Basel, Bellinzona, Lausanne (Panobinostat (LBH589), Carboplatin and Paclitaxel)

        Unknown status
        • Advanced Solid Tumors
        • Panobinostat (LBH589), Carboplatin and Paclitaxel
        • Basel, Switzerland
        • +2 more
        Sep 12, 2011

        NSCLC Trial in China (pemetrexed, docetaxel)

        Completed
        Has Results
        • Non-Small Cell Lung Cancer
        • Beijing, China
        • +6 more
        Apr 8, 2011

        Metastatic NSCLC Trial in Worldwide (nimotuzumab)

        Terminated
        • Metastatic Non-Small Cell Lung Cancer
        • New Port Richey, Florida
        • +14 more
        Jun 30, 2011

        Iressa Case Control Study in Japan

        Completed
        • Non-small Cell Lung Cancer
          • Nagoya, Aichi, Japan
          • +43 more
          Jan 27, 2011

          NSCLC, Carcinoma, Small Cell Lung, Mesothelioma Trial in Arnhem (N-Acetylcysteine, Placebo)

          Unknown status
          • Carcinoma, Non-Small-Cell Lung
          • +2 more
          • Arnhem, Gelderland, Netherlands
            Rijnstate Hospital
          Aug 8, 2011

          Lung Cancer Trial in Goyang-si (Oxaliplatin, Gemcitabine)

          Unknown status
          • Lung Cancer
          • Goyang-si, Gyeonggi-dog, Korea, Republic of
            National Cancer Center, Korea
          Oct 22, 2010

          Lung Cancer Trial in Goyang-si (gemcitabine, Oxaliplatin, Cisplatin)

          Unknown status
          • Lung Cancer
          • Goyang-si, Gyeonggi-do, Korea, Republic of
            National Cancer Center, Korea
          Oct 22, 2010

          NSCLC Trial in Antwerpen, Edegem, Wilrijk (cisplatin/docetaxel, cisplatin/vinorelbine)

          Completed
          • Non-small Cell Lung Cancer
          • Antwerpen, Antwerp, Belgium
          • +2 more
          Nov 29, 2010

          Carcinoma, Squamous Cell Trial in Vienna (Docetaxel + CDDP, docetaxel + CDDP)

          Completed
          • Carcinoma, Squamous Cell
          • Docetaxel + CDDP
          • docetaxel + CDDP
          • Vienna, Austria
            Sanofi-Aventis Administrative Office
          Sep 13, 2010

          Pemetrexed in Advanced Non-small Cell Lung Cancer

          Unknown status
          • Non-small Cell Lung Cancer (NSCLC)
            • Rozzano, Milano, Italy
              Istituto Clinico Humanitas
            Oct 11, 2010

            NSCLC Trial in Chongqin (radiotherapy combined with EP, radiotherapy / EP combined with recombinant human endostatin)

            Unknown status
            • Non-small Cell Lung Cancer
            • radiotherapy combined with EP
            • radiotherapy / EP combined with recombinant human endostatin
            • Chongqin, China
              Daping Hospital
            Sep 28, 2010

            Advanced NSCLC Trial in Seoul (Irinotecan, Cisplatin, TS-1 (S-1))

            Unknown status
            • Advanced Non-Small Cell Lung Cancer
            • Seoul, Korea, Republic of
              Asan Medical Center
            Oct 22, 2010

            NSCLC Trial in Chongqing (Gemcitabine, Nedaplatin, iV, 3DCRT, Gemcitabine,Nedaplatin, BAI)

            Unknown status
            • Non-small Cell Lung Cancer
            • Gemcitabine, Nedaplatin, iV
            • +2 more
            • Chongqing, China
              The 3rd Affiliated Hospital of the 3rd Military Hospital
            Sep 13, 2010

            Advanced Non-Small Cell Lung Cancer and Clinical Outcomes in

            Completed
            • Lung Cancer
              • Bangkok, Thailand
                Research Site
              Oct 6, 2010